Johnson & Johnson has reported new phase 3 data with its FcRn blocker nipocalimab in generalised myasthenia gravis (gMG), pointing to data that it says differentiates it from other drugs in the class.

The alternative text for this image may have been generated using AI. Macrophages have a key role in atherosclerosis through two processes: first, the production of inflammatory mediators; and second, ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

We'll show you how to combine Infinite Arrows, Explosive Arrows, and more for the best bow build in Crimson Desert.

Jiaying This is The English We Speak from BBC Learning English and we’re talking about the phrase ‘another string to your bow’ which describes having an additional skill to use if the first skill ...